A citation-based method for searching scientific literature

Jonathan L Digby-Bell, Raja Atreya, Giovanni Monteleone, Nick Powell. Nat Rev Gastroenterol Hepatol 2020
Times Cited: 49







List of co-cited articles
290 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Siew C Ng, Hai Yun Shi, Nima Hamidi, Fox E Underwood, Whitney Tang, Eric I Benchimol, Remo Panaccione, Subrata Ghosh, Justin C Y Wu, Francis K L Chan,[...]. Lancet 2017
24

Ulcerative colitis.
Ryan Ungaro, Saurabh Mehandru, Patrick B Allen, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Lancet 2017
16

Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Heike Schmitt, Ulrike Billmeier, Walburga Dieterich, Timo Rath, Sophia Sonnewald, Stephen Reid, Simon Hirschmann, Kai Hildner, Maximilian J Waldner, Jonas Mudter,[...]. Gut 2019
87
16

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.
Fernando Gomollón, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James O Lindsay, Laurent Peyrin-Biroulet, Garret J Cullen, Marco Daperno, Torsten Kucharzik,[...]. J Crohns Colitis 2017
14

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
Nathaniel R West, Ahmed N Hegazy, Benjamin M J Owens, Samuel J Bullers, Bryan Linggi, Sofia Buonocore, Margherita Coccia, Dieter Görtz, Sébastien This, Krista Stockenhuber,[...]. Nat Med 2017
360
14


Crohn's disease.
Joana Torres, Saurabh Mehandru, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet. Lancet 2017
922
14

Inflammatory bowel disease.
Clara Abraham, Judy H Cho. N Engl J Med 2009
12

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease.
Raja Atreya, Helmut Neumann, Clemens Neufert, Maximilian J Waldner, Ulrike Billmeier, Yurdagül Zopf, Marcus Willma, Christine App, Tino Münster, Hermann Kessler,[...]. Nat Med 2014
244
12

Cytokines in inflammatory bowel disease.
Markus F Neurath. Nat Rev Immunol 2014
10

Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances.
Sebastian Zundler, Emily Becker, Lisa Lou Schulze, Markus F Neurath. Gut 2019
56
10

Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease.
Bram Verstockt, Sare Verstockt, Jonas Dehairs, Vera Ballet, Helene Blevi, Willem-Jan Wollants, Christine Breynaert, Gert Van Assche, Séverine Vermeire, Marc Ferrante. EBioMedicine 2019
76
10

Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis.
Christopher S Smillie, Moshe Biton, Jose Ordovas-Montanes, Keri M Sullivan, Grace Burgin, Daniel B Graham, Rebecca H Herbst, Noga Rogel, Michal Slyper, Julia Waldman,[...]. Cell 2019
388
10

Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy.
Jerome C Martin, Christie Chang, Gilles Boschetti, Ryan Ungaro, Mamta Giri, John A Grout, Kyle Gettler, Ling-Shiang Chuang, Shikha Nayar, Alexander J Greenstein,[...]. Cell 2019
256
10

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
Luke Jostins, Stephan Ripke, Rinse K Weersma, Richard H Duerr, Dermot P McGovern, Ken Y Hui, James C Lee, L Philip Schumm, Yashoda Sharma, Carl A Anderson,[...]. Nature 2012
10

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
Subra Kugathasan, Lee A Denson, Thomas D Walters, Mi-Ok Kim, Urko M Marigorta, Melanie Schirmer, Kajari Mondal, Chunyan Liu, Anne Griffiths, Joshua D Noe,[...]. Lancet 2017
335
10


Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease.
Matthias Friedrich, Mathilde Pohin, Fiona Powrie. Immunity 2019
246
10

Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Raja Atreya, Markus F Neurath, Britta Siegmund. Front Med (Lausanne) 2020
35
14

The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition.
Pamela V Chang, Liming Hao, Stefan Offermanns, Ruslan Medzhitov. Proc Natl Acad Sci U S A 2014
996
8

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.
Fernando Magro, Paolo Gionchetti, Rami Eliakim, Sandro Ardizzone, Alessandro Armuzzi, Manuel Barreiro-de Acosta, Johan Burisch, Krisztina B Gecse, Ailsa L Hart, Pieter Hindryckx,[...]. J Crohns Colitis 2017
881
8


Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.
Remo Panaccione, Subrata Ghosh, Stephen Middleton, Juan R Márquez, Boyd B Scott, Laurence Flint, Hubert J F van Hoogstraten, Annie C Chen, Hanzhe Zheng, Silvio Danese,[...]. Gastroenterology 2014
581
8

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Bruce E Sands, Laurent Peyrin-Biroulet, Edward V Loftus, Silvio Danese, Jean-Frédéric Colombel, Murat Törüner, Laimas Jonaitis, Brihad Abhyankar, Jingjing Chen, Raquel Rogers,[...]. N Engl J Med 2019
277
8

Infliximab, azathioprine, or combination therapy for Crohn's disease.
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, Gerassimos J Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert D'Haens, Robert H Diamond, Delma L Broussard,[...]. N Engl J Med 2010
8

Immunity, inflammation, and allergy in the gut.
Thomas T Macdonald, Giovanni Monteleone. Science 2005
679
8


Current and emerging therapeutic targets for IBD.
Markus F Neurath. Nat Rev Gastroenterol Hepatol 2017
293
8

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.
I Arijs, K Li, G Toedter, R Quintens, L Van Lommel, K Van Steen, P Leemans, G De Hertogh, K Lemaire, M Ferrante,[...]. Gut 2009
260
8

Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
Matthias Jürgens, Rüdiger P Laubender, Franziska Hartl, Maria Weidinger, Julia Seiderer, Johanna Wagner, Martin Wetzke, Florian Beigel, Simone Pfennig, Johannes Stallhofer,[...]. Am J Gastroenterol 2010
120
8

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD.
Renaud Gaujoux, Elina Starosvetsky, Naama Maimon, Francesco Vallania, Haggai Bar-Yoseph, Sigal Pressman, Roni Weisshof, Idan Goren, Keren Rabinowitz, Matti Waterman,[...]. Gut 2019
100
8

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
Konstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, Peter M Irving, Niels Vande Casteele, Patricia L Kozuch, Laura E Raffals, Leonard Baidoo, Brian Bressler, Shane M Devlin,[...]. Clin Gastroenterol Hepatol 2019
140
8

The global burden of IBD: from 2015 to 2025.
Gilaad G Kaplan. Nat Rev Gastroenterol Hepatol 2015
8

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study.
Brian G Feagan, William J Sandborn, Geert D'Haens, Julián Panés, Arthur Kaser, Marc Ferrante, Edouard Louis, Denis Franchimont, Olivier Dewit, Ursula Seidler,[...]. Lancet 2017
267
8

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
893
8

Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.
Bruce E Sands, Jingjing Chen, Brian G Feagan, Mark Penney, William A Rees, Silvio Danese, Peter D R Higgins, Paul Newbold, Raffaella Faggioni, Kaushik Patra,[...]. Gastroenterology 2017
164
8

Distinct profiles of effector cytokines mark the different phases of Crohn's disease.
Francesca Zorzi, Ivan Monteleone, Massimiliano Sarra, Emma Calabrese, Irene Marafini, Micaela Cretella, Silvia Sedda, Livia Biancone, Francesco Pallone, Giovanni Monteleone. PLoS One 2013
68
8

Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study.
Jeffrey S Hyams, Sonia Davis Thomas, Nathan Gotman, Yael Haberman, Rebekah Karns, Melanie Schirmer, Angela Mo, David R Mack, Brendan Boyle, Anne M Griffiths,[...]. Lancet 2019
69
8

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.
Jason Lloyd-Price, Cesar Arze, Ashwin N Ananthakrishnan, Melanie Schirmer, Julian Avila-Pacheco, Tiffany W Poon, Elizabeth Andrews, Nadim J Ajami, Kevin S Bonham, Colin J Brislawn,[...]. Nature 2019
871
6

Microbial genes and pathways in inflammatory bowel disease.
Melanie Schirmer, Ashley Garner, Hera Vlamakis, Ramnik J Xavier. Nat Rev Microbiol 2019
227
6

Effect of Enterococcus faecalis 2001 on colitis and depressive-like behavior in dextran sulfate sodium-treated mice: involvement of the brain-gut axis.
Kohei Takahashi, Osamu Nakagawasai, Wataru Nemoto, Takayo Odaira, Wakana Sakuma, Hiroshi Onogi, Hiroaki Nishijima, Ryuji Furihata, Yukio Nemoto, Hiroyuki Iwasa,[...]. J Neuroinflammation 2019
30
10

Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases?
Parambir S Dulai, Siddharth Singh, Niels Vande Casteele, Brigid S Boland, Jesus Rivera-Nieves, Peter B Ernst, Lars Eckmann, Kim E Barrett, John T Chang, William J Sandborn. Clin Gastroenterol Hepatol 2019
55
6

Vedolizumab as induction and maintenance therapy for Crohn's disease.
William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel, Bruce E Sands, Milan Lukas, Richard N Fedorak, Scott Lee, Brian Bressler,[...]. N Engl J Med 2013
6

Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.
Niels Vande Casteele, Marc Ferrante, Gert Van Assche, Vera Ballet, Griet Compernolle, Kristel Van Steen, Steven Simoens, Paul Rutgeerts, Ann Gils, Séverine Vermeire. Gastroenterology 2015
588
6

Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease.
Ingrid Arijs, Roel Quintens, Leentje Van Lommel, Kristel Van Steen, Gert De Hertogh, Katleen Lemaire, Anica Schraenen, Clémentine Perrier, Gert Van Assche, Séverine Vermeire,[...]. Inflamm Bowel Dis 2010
122
6

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu'Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger,[...]. Gut 2019
688
6

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.
Alessandra Geremia, Carolina V Arancibia-Cárcamo, Myles P P Fleming, Nigel Rust, Baljit Singh, Neil J Mortensen, Simon P L Travis, Fiona Powrie. J Exp Med 2011
472
6

STAR: ultrafast universal RNA-seq aligner.
Alexander Dobin, Carrie A Davis, Felix Schlesinger, Jorg Drenkow, Chris Zaleski, Sonali Jha, Philippe Batut, Mark Chaisson, Thomas R Gingeras. Bioinformatics 2013
6

Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis.
James C Lee, Paul A Lyons, Eoin F McKinney, John M Sowerby, Edward J Carr, Francesca Bredin, Hannah M Rickman, Huzefa Ratlamwala, Alexander Hatton, Tim F Rayner,[...]. J Clin Invest 2011
202
6

Personalised medicine in Crohn's disease.
Nurulamin M Noor, Bram Verstockt, Miles Parkes, James C Lee. Lancet Gastroenterol Hepatol 2020
31
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.